1. Home
  2. ABBV
  3. ABBV News

Latest AbbVie Inc. (ABBV) News on January 21, 2025

Count on Dividend King Pepsi (PEP) for Stability in a Volatile Market
ABBV

TipRanks

2 days ago

Count on Dividend King Pepsi (PEP) for Stability in a Volatile Market

Why Is AbbVie Inc. (ABBV) Among Louis Navellier’s Top Long-term Stock Picks?
ABBV

Insider Monkey

3 days ago

Why Is AbbVie Inc. (ABBV) Among Louis Navellier’s Top Long-term Stock Picks?

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
ABBV

TipRanks

3 days ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales
ABBV

Zacks

3 days ago

Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
ABBV

Benzinga

4 days ago

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
ABBV

Yahoo Finance

4 days ago

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

ABBV

MT Newswires

4 days ago

Guggenheim Adjusts Price Target on AbbVie to $212 From $221, Maintains Buy Rating

ABBV

MT Newswires

4 days ago

Redburn Atlantic Adjusts Price Target on AbbVie to $216 From $214, Maintains Buy Rating

Why the Market Dipped But AbbVie (ABBV) Gained Today
ABBV

Zacks

4 days ago

Why the Market Dipped But AbbVie (ABBV) Gained Today

Humira Holds Firm at 72% Market Share-AbbVie Fends Off Biosimilar Surge
ABBV

GuruFocus.com

5 days ago

Humira Holds Firm at 72% Market Share-AbbVie Fends Off Biosimilar Surge

The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio
ABBV

Zacks

5 days ago

The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson
ABBV

BioPharma Dive

5 days ago

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson

JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole
ABBV

Clinical Trials Arena

5 days ago

JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole

Top Research Reports for Visa, AbbVie & Analog Devices
ABBV

Zacks

5 days ago

Top Research Reports for Visa, AbbVie & Analog Devices

AbbVie's $3.5 Billion Blow: Can Bold Bets Revive Its Profit Forecasts?
ABBV

GuruFocus.com

5 days ago

AbbVie's $3.5 Billion Blow: Can Bold Bets Revive Its Profit Forecasts?

AbbVie and Simcere Zaiming link to develop trispecific antibody
ABBV

Pharmaceutical Technology

6 days ago

AbbVie and Simcere Zaiming link to develop trispecific antibody

AbbVie Inc. (ABBV): An Undervalued Dividend Kings Stock to Invest in Now?
ABBV

Insider Monkey

7 days ago

AbbVie Inc. (ABBV): An Undervalued Dividend Kings Stock to Invest in Now?

AbbVie Falls 8% in 3 Months: Buy, Hold or Sell the Stock?
ABBV

Zacks

7 days ago

AbbVie Falls 8% in 3 Months: Buy, Hold or Sell the Stock?

AbCellera expands collaboration with AbbVie
ABBV

TipRanks

7 days ago

AbCellera expands collaboration with AbbVie

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
ABBV

Zacks

7 days ago

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

2 Brilliant Dividend Growth Stocks That Can Supercharge Your Portfolio
ABBV

Motley Fool

7 days ago

2 Brilliant Dividend Growth Stocks That Can Supercharge Your Portfolio

AbbVie Inc: An Exploration into Its Intrinsic Value
ABBV

GuruFocus.com

7 days ago

AbbVie Inc: An Exploration into Its Intrinsic Value

3 High-Yielding Dividend Stocks That Could Be Ideal Investments for Retirees
ABBV

Motley Fool

7 days ago

3 High-Yielding Dividend Stocks That Could Be Ideal Investments for Retirees

AbbVie (NYSE:ABBV) Is Paying Out A Larger Dividend Than Last Year
ABBV

Simply Wall St.

8 days ago

AbbVie (NYSE:ABBV) Is Paying Out A Larger Dividend Than Last Year

ABBV

MT Newswires

8 days ago

AbbVie, Simcere Zaiming Collaborate to Develop Bone Marrow Cancer Treatment

AbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma
ABBV

PR Newswire

8 days ago

AbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

3 High-Yield Dividend Stocks to Buy in 2025
ABBV

Motley Fool

8 days ago

3 High-Yield Dividend Stocks to Buy in 2025

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program
ABBV

PR Newswire

8 days ago

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program

AbbVie (NYSE:ABBV) Has A Pretty Healthy Balance Sheet
ABBV

Simply Wall St.

9 days ago

AbbVie (NYSE:ABBV) Has A Pretty Healthy Balance Sheet

3 Incredible Dividend Stocks to Buy in 2025
ABBV

Motley Fool

10 days ago

3 Incredible Dividend Stocks to Buy in 2025

ABBV

MT Newswires

11 days ago

Redburn Atlantic Adjusts Price Target on AbbVie to $214 From $216, Keeps Buy Rating

Top Stock Movers Now: Constellation Brands, Allstate, Delta Air Lines, and More
ABBV

Investopedia

11 days ago

Top Stock Movers Now: Constellation Brands, Allstate, Delta Air Lines, and More

AbbVie Takes $3.5B Impairment Charge for Failed Schizophrenia Drug
ABBV

Investopedia

11 days ago

AbbVie Takes $3.5B Impairment Charge for Failed Schizophrenia Drug

AbbVie to Post $3.5 Billion Impairment Charge on Failed Cerevel Drug
ABBV

The Wall Street Journal

11 days ago

AbbVie to Post $3.5 Billion Impairment Charge on Failed Cerevel Drug

ABBV

MT Newswires

11 days ago

AbbVie to Book $3.5 Billion Impairment Charge Related to Potential Antipsychotic Drug Emraclidine

Pfizer’s PD-1 drug succeeds; AbbVie writes down $3.5B in Cerevel assets
ABBV

BioPharma Dive

11 days ago

Pfizer’s PD-1 drug succeeds; AbbVie writes down $3.5B in Cerevel assets

AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ABBV

PR Newswire

12 days ago

AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
ABBV

Zacks

13 days ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

ABBV

MT Newswires

13 days ago

Truist Trims Price Target on AbbVie to $211 From $215, Keeps Buy Rating

AbbVie (ABBV) Stock Moves -0.32%: What You Should Know
ABBV

Zacks

13 days ago

AbbVie (ABBV) Stock Moves -0.32%: What You Should Know

Will AbbVie (ABBV) Beat Estimates Again in Its Next Earnings Report?
ABBV

Zacks

14 days ago

Will AbbVie (ABBV) Beat Estimates Again in Its Next Earnings Report?

ABBV

MT Newswires

14 days ago

Sector Update: Health Care Stocks Mixed Premarket Tuesday

CoolMonth is Back With Deals on CoolSculpting® Elite by Allergan Aesthetics
ABBV

PR Newswire

14 days ago

CoolMonth is Back With Deals on CoolSculpting® Elite by Allergan Aesthetics

AbbVie Cuts 2024 EPS Guidance to Include Acquisition Costs
ABBV

Zacks

14 days ago

AbbVie Cuts 2024 EPS Guidance to Include Acquisition Costs

ABBV

MT Newswires

14 days ago

AbbVie Lowers Q4 and Full-Year Earnings Outlook on $1.6 Billion Acquired IPR&D and Milestones Expense

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value
ABBV

GuruFocus.com

14 days ago

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value

AbbVie cuts 2024 profit forecast on acquisition expenses
ABBV

Reuters

14 days ago

AbbVie cuts 2024 profit forecast on acquisition expenses

ABBV

Argus Research

15 days ago

Weekly Stock List

The Smartest Dividend Stocks to Buy With $500 Right Now
ABBV

Motley Fool

15 days ago

The Smartest Dividend Stocks to Buy With $500 Right Now

2 No-Brainer Dividend Stocks to Buy With $250 in 2025
ABBV

Motley Fool

15 days ago

2 No-Brainer Dividend Stocks to Buy With $250 in 2025

AbbVie Inc. (NYSE:ABBV) is largely controlled by institutional shareholders who own 73% of the company
ABBV

Simply Wall St.

17 days ago

AbbVie Inc. (NYSE:ABBV) is largely controlled by institutional shareholders who own 73% of the company

3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
ABBV

Motley Fool

17 days ago

3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call
ABBV

PR Newswire

18 days ago

AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call

The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer
ABBV

Zacks

18 days ago

The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer

What RFK Jr.’s Dislike for Drug TV Commercials Could Mean for the Ad Industry
ABBV

The Wall Street Journal

19 days ago

What RFK Jr.’s Dislike for Drug TV Commercials Could Mean for the Ad Industry

5 Large Drug Stocks to Keep An Eye On in the New Year
ABBV

Zacks

19 days ago

5 Large Drug Stocks to Keep An Eye On in the New Year

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value
ABBV

GuruFocus.com

19 days ago

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value

Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.
ABBV

Barrons.com

20 days ago

Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.

AbbVie (ABBV) Gains As Market Dips: What You Should Know
ABBV

Zacks

20 days ago

AbbVie (ABBV) Gains As Market Dips: What You Should Know

AbbVie (ABBV) Upgraded to Buy: What Does It Mean for the Stock?
ABBV

Zacks

21 days ago

AbbVie (ABBV) Upgraded to Buy: What Does It Mean for the Stock?

10 stocks retail investors craved in 2024
ABBV

Yahoo Finance

21 days ago

10 stocks retail investors craved in 2024

Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year?
ABBV

Zacks

21 days ago

Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year?

Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet
ABBV

Zacks

21 days ago

Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet

Is AbbVie Inc. (ABBV) the Best Dividend Stock of 2024?
ABBV

Insider Monkey

21 days ago

Is AbbVie Inc. (ABBV) the Best Dividend Stock of 2024?

Is AbbVie Inc. (ABBV) the Best Pharma Dividend Stock to Buy In 2024?
ABBV

Insider Monkey

21 days ago

Is AbbVie Inc. (ABBV) the Best Pharma Dividend Stock to Buy In 2024?

Is AbbVie Inc. (ABBV) the Best Stock for 10 Years?
ABBV

Insider Monkey

22 days ago

Is AbbVie Inc. (ABBV) the Best Stock for 10 Years?

Credit Spreads Haven’t Looked This Good Since the 2000s. Can They Get Better?
ABBV

The Wall Street Journal

22 days ago

Credit Spreads Haven’t Looked This Good Since the 2000s. Can They Get Better?

Is AbbVie Inc. (ABBV) the Best Dividend Growth Stock to Buy and Hold in 2025?
ABBV

Insider Monkey

22 days ago

Is AbbVie Inc. (ABBV) the Best Dividend Growth Stock to Buy and Hold in 2025?

Those who invested in AbbVie (NYSE:ABBV) five years ago are up 149%
ABBV

Simply Wall St.

23 days ago

Those who invested in AbbVie (NYSE:ABBV) five years ago are up 149%

The Smartest Dividend Stocks to Buy With $1,000 Right Now
ABBV

Motley Fool

a month ago

The Smartest Dividend Stocks to Buy With $1,000 Right Now

AbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth Knowing
ABBV

Zacks

a month ago

AbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Why AbbVie Inc. (ABBV) Is Among the Best Stocks to Buy and Hold for 3 Years?
ABBV

Insider Monkey

a month ago

Why AbbVie Inc. (ABBV) Is Among the Best Stocks to Buy and Hold for 3 Years?

Exploring Three High Growth Tech Stocks In The United States
ABBV

Simply Wall St.

a month ago

Exploring Three High Growth Tech Stocks In The United States

Invest with Confidence: Intrinsic Value Unveiled of AbbVie Inc
ABBV

GuruFocus.com

a month ago

Invest with Confidence: Intrinsic Value Unveiled of AbbVie Inc

AbbVie (ABBV) Benefitted from Top-Line Growth From Its Immunosuppressive Drugs
ABBV

Insider Monkey

a month ago

AbbVie (ABBV) Benefitted from Top-Line Growth From Its Immunosuppressive Drugs

Is AbbVie Stock a Buy?
ABBV

Motley Fool

a month ago

Is AbbVie Stock a Buy?

2 Excellent Dividend Stocks to Buy on the Dip
ABBV

Motley Fool

a month ago

2 Excellent Dividend Stocks to Buy on the Dip

AbbVie Insiders Sell US$56m Of Stock, Possibly Signalling Caution
ABBV

Simply Wall St.

a month ago

AbbVie Insiders Sell US$56m Of Stock, Possibly Signalling Caution

2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
ABBV

Motley Fool

a month ago

2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

Is AbbVie Inc. (ABBV) the Best Dividend Stock for Steady Income?
ABBV

Insider Monkey

a month ago

Is AbbVie Inc. (ABBV) the Best Dividend Stock for Steady Income?

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
ABBV

Motley Fool

a month ago

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals
ABBV

Zacks

a month ago

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals

AbbVie's atogepant and onabotulinumtoxinA receive strong recommendations in the newly updated Canadian Headache Society (CHS) Migraine Prevention Guideline
ABBV

CNW Group

a month ago

AbbVie's atogepant and onabotulinumtoxinA receive strong recommendations in the newly updated Canadian Headache Society (CHS) Migraine Prevention Guideline

2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond
ABBV

Motley Fool

a month ago

2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond

Is AbbVie Inc. (ABBV) the Safest Dividend Stock to Invest In Now?
ABBV

Insider Monkey

a month ago

Is AbbVie Inc. (ABBV) the Safest Dividend Stock to Invest In Now?

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
ABBV

Zacks

a month ago

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

AbbVie’s tavapadon achieves positive topline results in Phase III TEMPO-2 trial
ABBV

Clinical Trials Arena

a month ago

AbbVie’s tavapadon achieves positive topline results in Phase III TEMPO-2 trial

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study
ABBV

Zacks

a month ago

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study

Strength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength?
ABBV

Zacks

a month ago

Strength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength?

ABBV

MT Newswires

a month ago

Piper Sandler Adjusts AbbVie Price Target to $220 From $212, Maintains Overweight Rating

4 Big Drug Stocks That May Continue to Outperform in 2025
ABBV

Zacks

a month ago

4 Big Drug Stocks That May Continue to Outperform in 2025

AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back?
ABBV

Investor's Business Daily

a month ago

AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back?

AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors
ABBV

Zacks

a month ago

AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors

ABBV's Acquisition Spree Continues: Buy, Sell or Hold the Stock?
ABBV

Zacks

a month ago

ABBV's Acquisition Spree Continues: Buy, Sell or Hold the Stock?

ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline
ABBV

Zacks

a month ago

ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline

EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease
ABBV

Zacks

a month ago

EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease

AbbVie to acquire Nimble Therapeutics for $200m
ABBV

Pharmaceutical Technology

a month ago

AbbVie to acquire Nimble Therapeutics for $200m

3 closely watched drugs that failed in the clinic
ABBV

Pharma Voice

a month ago

3 closely watched drugs that failed in the clinic

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
ABBV

Motley Fool

a month ago

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

This Drugmaker's (ABBV) Parkinson's Medication Just Cleared A Key Hurdle – Is It Primed For A Monster Year In 2025?
ABBV

Benzinga

a month ago

This Drugmaker's (ABBV) Parkinson's Medication Just Cleared A Key Hurdle – Is It Primed For A Monster Year In 2025?

Share on Social Networks: